Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 3
2007 2
2008 6
2009 5
2010 8
2011 10
2012 14
2013 11
2014 18
2015 19
2016 16
2017 16
2018 17
2019 9
2020 13
2021 14
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Mucopolysaccharidosis Type I.
Kubaski F, de Oliveira Poswar F, Michelin-Tirelli K, Matte UDS, Horovitz DD, Barth AL, Baldo G, Vairo F, Giugliani R. Kubaski F, et al. Among authors: matte uds. Diagnostics (Basel). 2020 Mar 16;10(3):161. doi: 10.3390/diagnostics10030161. Diagnostics (Basel). 2020. PMID: 32188113 Free PMC article. Review.
Spotlight edition on South America.
Matte U, Peluffo H. Matte U, et al. Gene Ther. 2020 Feb;27(1-2):1. doi: 10.1038/s41434-020-0129-9. Epub 2020 Feb 25. Gene Ther. 2020. PMID: 32099107 No abstract available.
Cationic nanoemulsions as nucleic acids delivery systems.
Teixeira HF, Bruxel F, Fraga M, Schuh RS, Zorzi GK, Matte U, Fattal E. Teixeira HF, et al. Among authors: matte u. Int J Pharm. 2017 Dec 20;534(1-2):356-367. doi: 10.1016/j.ijpharm.2017.10.030. Epub 2017 Oct 13. Int J Pharm. 2017. PMID: 29038065 Review.
Emerging drugs for the treatment of mucopolysaccharidoses.
Giugliani R, Federhen A, Vairo F, Vanzella C, Pasqualim G, da Silva LM, Giugliani L, de Boer AP, de Souza CF, Matte U, Baldo G. Giugliani R, et al. Among authors: matte u. Expert Opin Emerg Drugs. 2016;21(1):9-26. doi: 10.1517/14728214.2016.1123690. Epub 2016 Jan 9. Expert Opin Emerg Drugs. 2016. PMID: 26751109 Review.
Genome editing in mucopolysaccharidoses and mucolipidoses.
Santos HS, Poletto E, Schuh R, Matte U, Baldo G. Santos HS, et al. Among authors: matte u. Prog Mol Biol Transl Sci. 2021;182:327-351. doi: 10.1016/bs.pmbts.2021.01.026. Epub 2021 Mar 1. Prog Mol Biol Transl Sci. 2021. PMID: 34175047
Guidelines for the management of mucopolysaccharidosis type I.
Martins AM, Dualibi AP, Norato D, Takata ET, Santos ES, Valadares ER, Porta G, de Luca G, Moreira G, Pimentel H, Coelho J, Brum JM, Semionato Filho J, Kerstenetzky MS, Guimarães MR, Rojas MV, Aranda PC, Pires RF, Faria RG, Mota RM, Matte U, Guedes ZC. Martins AM, et al. Among authors: matte u. J Pediatr. 2009 Oct;155(4 Suppl):S32-46. doi: 10.1016/j.jpeds.2009.07.005. J Pediatr. 2009. PMID: 19765409 Review. No abstract available.
175 results